Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors YE Nikiforov, RR Seethala, G Tallini, ZW Baloch, F Basolo, ... JAMA oncology 2 (8), 1023-1029, 2016 | 1444 | 2016 |
A large multicenter correlation study of thyroid nodule cytopathology and histopathology CCC Wang, L Friedman, GC Kennedy, H Wang, E Kebebew, DL Steward, ... Thyroid 21 (3), 243-251, 2011 | 425 | 2011 |
Papillary thyroid carcinoma variants RV Lloyd, D Buehler, E Khanafshar Head and neck pathology 5, 51-56, 2011 | 394 | 2011 |
Molecular testing for somatic mutations improves the accuracy of thyroid fine‐needle aspiration biopsy W Moses, J Weng, I Sansano, M Peng, E Khanafshar, BM Ljung, QY Duh, ... World Journal of Surgery 34 (11), 2589-2594, 2010 | 214 | 2010 |
Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? GG Fernandez‐Ranvier, E Khanafshar, K Jensen, R Zarnegar, J Lee, ... Cancer 110 (2), 255-264, 2007 | 200 | 2007 |
Higher rate of BRAF mutation in papillary thyroid cancer over time A single‐institution study A Mathur, W Moses, R Rahbari, E Khanafshar, QY Duh, O Clark, ... Cancer 117 (19), 4390-4395, 2011 | 137 | 2011 |
Defining a molecular phenotype for benign and malignant parathyroid tumors GG Fernandez‐Ranvier, E Khanafshar, D Tacha, M Wong, E Kebebew, ... Cancer 115 (2), 334-344, 2009 | 135 | 2009 |
Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling GG Fernandez-Ranvier, J Weng, RF Yeh, E Khanafshar, I Suh, C Barker, ... Archives of surgery 143 (9), 841-846, 2008 | 131 | 2008 |
Transmission of hepatitis B infection from hepatitis B core antibody–positive liver allografts is prevented by lamivudine therapy SY Andy, JM Vierling, SD Colquhoun, WS Arnaout, CK Chan, ... Liver Transplantation 7 (6), 513-517, 2001 | 119 | 2001 |
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists RR Seethala, ZW Baloch, JA Barletta, E Khanafshar, O Mete, PM Sadow, ... Modern Pathology 31 (1), 39-55, 2018 | 117 | 2018 |
Identification of differentially expressed microRNA in parathyroid tumors R Rahbari, AK Holloway, M He, E Khanafshar, OH Clark, E Kebebew Annals of Surgical Oncology 18, 1158-1165, 2011 | 94 | 2011 |
MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets GY Meyer-Rochow, NE Jackson, JV Conaglen, DE Whittle, ... Endocrine-related cancer 17 (3), 835, 2010 | 94 | 2010 |
Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid RS Sippel, DM Elaraj, E Khanafshar, R Zarnegar, E Kebebew, QY Duh, ... World journal of surgery 32, 702-707, 2008 | 84 | 2008 |
The spectrum of papillary thyroid carcinoma variants E Khanafshar, RV Lloyd Advances in anatomic pathology 18 (1), 90-97, 2011 | 56 | 2011 |
A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy A Mathur, J Weng, W Moses, SM Steinberg, R Rahabari, M Kitano, ... Surgery 148 (6), 1170-1177, 2010 | 56 | 2010 |
Inflammatory myofibroblastic tumor of the breast E Khanafshar, J Phillipson, DP Schammel, L Minobe, J Cymerman, ... Annals of diagnostic pathology 9 (3), 123-129, 2005 | 55 | 2005 |
Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid? RS Sippel, DM Elaraj, E Khanafshar, E Kebebew, QY Duh, OH Clark Surgery 142 (6), 851-857. e2, 2007 | 41 | 2007 |
Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation W Moses, J Weng, E Khanafshar, QY Duh, OH Clark, E Kebebew Journal of Surgical Research 160 (2), 179-183, 2010 | 38 | 2010 |
Does the 3‐gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? D Shibru, J Hwang, E Khanafshar, QY Duh, OH Clark, E Kebebew Cancer 113 (5), 930-935, 2008 | 38 | 2008 |
Microscopic positive tumor margin does not increase the risk of recurrence in patients with T1–T2 well-differentiated thyroid cancer WP Kluijfhout, JD Pasternak, JS Kwon, J Lim, WT Shen, JE Gosnell, ... Annals of surgical oncology 23, 1446-1451, 2016 | 37 | 2016 |